Allan Coukell, The Pew Charitable Trusts' senior health programs director, says the U.S. should consider how other… Read more
- What's in Store for Humana after the CVS-Aetna Merger?
- RTI Health Solutions Breaks Down ISPOR/ISPE RWE Guidelines
- Should the U.S. Take Notes on Drug Prices?
- What Comes after Signing a Risk-Sharing Contract?
- Biopharma Consultant Releases New Book
- FDA Issues 3 New Guidances on Digital Health
- Report: Health Care Spending Grows 4.3 Percent in 2016
- New Syndicated Report - Orphan Drug Launch Strategies: Case Studies
- NPC's Dubois: Address U.S. Health Care Spending Now, Not Later
- CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials
Via Deloitte: "In this third post in our series on navigating strategic risk contracting, we’ll discuss what takes place after negotiations conclude… Read more
A new report from the Centers for Medicare and Medicaid Services Office of the Actuary found U.S. health care spending grew at a rate of 4.3 percent… Read more
When a historic deal such as the CVS Health-Aetna acquisition hits the U.S. market, it could set off a chain reaction. Now, taking notes from past… Read more
RTI Health Solutions recently posted a simple guide to help understand the upcoming ISPOR/ISPE real-world evidence guidelines. Below are a couple… Read more
A well-known consultant for the biopharmaceutical and diagnostics industries, Harry Glorikian, recently released his latest book titled "MoneyBall… Read more